Accord cleans up at 2022 Global Generics and Biosimilars Awards

Nov 2, 2022

Accord Healthcare was the clear winner at the Global Generics and Biosimilars Awards which were presented on 2 November in Frankfurt, achieving “Biosimilar Initiative of the Year”, “Company of the Year”, “Value Added Medicine Initiative of the Year”, and “Regulatory Achievement of the Year”.  Dr Reddy’s, Samsung Bioepis, Stada and Shanghai Henlius Biotech were also winners in the following categories:

  • Dr Reddy’s Laboratories: Company of the Year, Americas;
  • Samsung Bioepis: Company of the Year, Asia-Pacific;
  • Stada: Intellectual Property Strategy of the Year; and
  • Shanghai Henlius Biotech: BD of the year.
Print Page Mail Article